SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
不安诗云
Lv3
230 积分
2023-08-01 加入
最近求助
最近应助
互助留言
Clinical perspective: Antibody-drug conjugates for the treatment of HER2-positive breast cancer
21天前
已完结
Residual disease post neoadjuvant chemo-immunotherapy in early triple-negative breast cancer: Does it help tailor adjuvant treatment?
1个月前
已完结
Exploring the therapeutic potential of ADC combination for triple-negative breast cancer
3个月前
已完结
Exploring the therapeutic potential of ADC combination for triple-negative breast cancer
5个月前
已完结
Clinical development of antibody-drug conjugates in triple negative breast cancer: can we jump higher?
5个月前
已完结
The emergence of targeted therapy for HER2-low triple-negative breast cancer: a review of fam-trastuzumab deruxtecan
5个月前
已完结
Neoadjuvant chemotherapy in hormone receptor-positive/HER2-negative early breast cancer: When, why and what?
6个月前
已完结
What Is the Role of Neoadjuvant Endocrine Therapy for Breast Cancer?
6个月前
已完结
Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial
6个月前
已完结
Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial
6个月前
已完结
没有进行任何应助
谢谢
8个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论